Chemoinformaics analysis of Chrysophanol-1-Mono-Beta-D-Glucoside
| Molecular Weight | 502.428 | nRot | 6 |
| Heavy Atom Molecular Weight | 480.252 | nRig | 26 |
| Exact Molecular Weight | 502.111 | nRing | 4 |
| Solubility: LogS | -3.563 | nHRing | 1 |
| Solubility: LogP | 1.476 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 12 |
| nHA | 11 | APOL | 64.3734 |
| nHD | 5 | BPOL | 30.7506 |
| QED | 0.218 |
| Synth | 3.987 |
| Natural Product Likeliness | 1.73 |
| NR-PPAR-gamma | 0.98 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.958 |
| HIA | 0.917 |
| CACO-2 | -6.335 |
| MDCK | 0.0000121 |
| BBB | 0.053 |
| PPB | 0.846601 |
| VDSS | 0.354 |
| FU | 0.0389878 |
| CYP1A2-inh | 0.045 |
| CYP1A2-sub | 0.026 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.047 |
| CYP2c9-inh | 0.01 |
| CYP2c9-sub | 0.187 |
| CYP2d6-inh | 0.023 |
| CYP2d6-sub | 0.128 |
| CYP3a4-inh | 0.051 |
| CYP3a4-sub | 0.084 |
| CL | 5.476 |
| T12 | 0.7 |
| hERG | 0.027 |
| Ames | 0.912 |
| ROA | 0.056 |
| SkinSen | 0.207 |
| Carcinogencity | 0.395 |
| EI | 0.043 |
| Respiratory | 0.018 |
| NR-Aromatase | 0.039 |
| Antiviral | Yes |
| Prediction | 0.843696 |